Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

ATXI — Avenue Therapeutics, Inc. Dilution Risk Tracker

Track ATXI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATXI — Get alerts when the score changes →

As of October 13, 2026, Avenue Therapeutics, Inc. (ATXI) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Avenue Therapeutics, Inc. has a market capitalization of $1.32M, 3.29M shares outstanding. Stored dilution-related fields include 772.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 39%
🔄 Reverse Split model est. 55%
• 50-day avg $0.42 below $1 exchange minimum
📜 Warrant Exercise model 40%
• Significant warrants: 23% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track ATXI — Get forecast alerts →

Market Data

Market Cap$1.32M
Shares Outstanding3.29M
Float2.85M
Cash$6.94M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding3.29MVerified float table or market cache
Public Float2.85MVerified float table or market cache
Market Cap$1.32MMarket data cache
Cash Runway13.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants772.7KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

4.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ATXI for full holder detail →

Short Interest

Short Interest1
Days to Cover1.0
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-07
xbrl XBRL CONVERTIBLE 2019-03-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ATXI Dilution Snapshot

Avenue Therapeutics, Inc. (ATXI) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ATXI's DilutionScore is currently 50/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 46/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202650/100MEDIUM13 days
Aug 22 – Sep 30, 202646/100MEDIUM40 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 16 – Aug 13, 202646/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track ATXI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ATXI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ATXI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations